Proteins from Mycobacterium tuberculosis: Difference between revisions

No edit summary
No edit summary
Line 69: Line 69:
=== Enoyl-Acyl-Carrier Protein Reductase <ref>PMID:19130456</ref>===
=== Enoyl-Acyl-Carrier Protein Reductase <ref>PMID:19130456</ref>===
[[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL). These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>.
[[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL). These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>.
===  Crystal structure of the essential biotin-dependent carboxylase AccA3 from Mycobacterium tuberculosis ===
<big>Matthew Bennett, Martin Högbom</big> <ref>pmid 28469974</ref>
<hr/>
<b>Molecular Tour</b><br>
Biotin-dependent acetyl-CoA carboxylases catalyze the committed step in type II fatty acid biosynthesis, the main route for production of membrane phospholipids in bacteria, and are considered a key target for antibacterial drug discovery. Here we describe the first structure of AccA3, an essential component of the acetyl-CoA carboxylase system in ''Mycobacterium tuberculosis'' (MTb). The structure, sequence comparisons, and modeling of ligand-bound states reveal that the ATP cosubstrate-binding site shows distinct differences compared to other bacterial and eukaryotic biotin carboxylases, including all human homologs. This suggests the possibility to design MTb AccA3 subtype-specific inhibitors.
''Mycobacterium tuberculosis'' <scene name='76/763765/Cv/2'>AccA3 adopts the ATPgrasp superfamily fold</scene>, and crystallized as a <scene name='76/763765/Cv/3'>dimer in the asymmetric unit</scene>. <scene name='76/763765/Cv/4'>The ordered structure of domain B is missing in chain B</scene>.
Previous structures have shown defined ‘open’ and ‘closed’ states of the B-domain<ref>pmid 19213731</ref><ref>pmid 7915138</ref>. In addition, the biotin carboxylase domain of pyruvate carboxylase from ''Bacillus thermodenitrificans'' displays what appears to be an intermediate, but defined, conformation <ref>pmid 17642515</ref>. In the current structure, however, while <scene name='76/763765/Cv/6'>protomer A</scene> represents the previously observed ‘closed’ state, <scene name='76/763765/Cv/7'>protomer B</scene> represent a different structural state where no conformation is present in high enough occupancy to be possible to reliably model. MTb AccA3, subunit A (blue) and subunit B (yellow), unbound BDC from Escherichia coli (gray) (PDB [[1bnc]]). Based on the location of the segment of positive difference density relative to protomer B, it is, however, clear that the location of the B-domain in the partially occupied structural state that gives rise to this density is not the same as either the previously described ‘closed’ or ‘open’ states. Rather, the density suggests an even more extended conformation of the B-domain relative to the rest of the protein. Together, the most likely interpretation of the combined structural data of biotin-dependent carboxylases is that the B-domain is dynamic over a continuum of conformations, or several defined conformations.
<scene name='76/763765/Cv/8'>Structural model</scene> of biotin and ADP binding in MTb AccA3 based on the biotin and ADP-bound ''Escherichia coli'' BDC (PDB [[3g8c]]). Substrate-bridging loop of ''MTb'' AccA3 rendered in pink and ''E. coli'' BDC in cyan.
</StructureSection>
</StructureSection>


Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky